Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trialSOUGLAKOS, J; SYRIGOS, K; GEORGOULIAS, V et al.Annals of oncology. 2004, Vol 15, Num 8, pp 1204-1209, issn 0923-7534, 6 p.Article

Dose escalation study on oxaliplatin and Capecitabine (Xeloda) in patients with advanced solid tumorsKAKOLYRIS, S; SOUGLAKOS, J; GEORGOULIAS, V et al.Oncology. 2004, Vol 66, Num 4, pp 253-259, issn 0030-2414, 7 p.Article

Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumoursANDROULAKIS, N; KOUROUSSIS, C; GEORGOULIAS, V et al.European journal of cancer (1990). 2002, Vol 38, Num 15, pp 1992-1997, issn 0959-8049Article

Phase I study of the gemcitbine/oxaliplatin combination in patients with advanced solid tumors : A preliminary reportMAVROUDIS, D; KOUROUSIS, C; KAKOLYRIS, S et al.Seminars in oncology. 2000, Vol 27, Num 1, pp 25-30, issn 0093-7754, SUP2Article

Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine : A multicenter phase II trialGEORGOULIAS, V; KOUROUSSIS, C; HATZAKIS, K et al.Journal of clinical oncology. 1999, Vol 17, Num 3, pp 914-920, issn 0732-183XArticle

Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinomaKAKOLYRIS, S; AGELIDOU, A; GEROYIANNI, A et al.Lung cancer. 2006, Vol 53, Num 1, pp 59-65, issn 0169-5002, 7 p.Article

FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIR (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC) : a multicentre randomised phase iii trial from the Hellenic Oncology Research Group (HORG)SOUGLAKOS, J; ANDROULAKIS, N; KALYKAKI, A et al.British journal of cancer. 2006, Vol 94, Num 6, pp 798-805, issn 0007-0920, 8 p.Article

Vinorelbine and cisplatin combination in pretreated patients with advanced non-small cell lung cancer pretreated with a taxane-based regimen : A multicenter phase II studyMAKRANTONAKIS, P; ZIOTOPOULOS, P; GEORGOULIAS, V et al.Lung cancer. 2006, Vol 53, Num 1, pp 85-90, issn 0169-5002, 6 p.Article

Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer : A phase II trialSOUGLAKOS, J; PALLIS, A; KAKOLYRIS, S et al.Oncology. 2005, Vol 69, Num 5, pp 384-390, issn 0030-2414, 7 p.Article

A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancerKAKOLYRIS, S; SOUGLAKOS, J; GEORGOULIAS, V et al.Oncology. 2001, Vol 60, Num 3, pp 207-213, issn 0030-2414Article

Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy : A report of five casesKOUROUSSIS, C; SAMONIS, G; ANDROULAKIS, N et al.American journal of clinical oncology. 2000, Vol 23, Num 3, pp 309-313, issn 0277-3732Article

Phase I study of weekly docetaxel and liposomal doxorubicin in patients with advanced solid tumorsKOUROUSSIS, Ch; ANDROULAKIS, N; VAMVAKAS, L et al.Oncology. 2005, Vol 69, Num 3, pp 202-207, issn 0030-2414, 6 p.Article

Front-line chemotherapy with docetaxel and gemcitabine administered every two weeks in patients with metastatic breast cancer: A multicenter phase II studyMAVROUDIS, D; MALAMOS, N; POLYZOS, A et al.Oncology. 2004, Vol 67, Num 3-4, pp 250-256, issn 0030-2414, 7 p.Article

Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II studySTATHOPOULOS, G. P; SYRIGOS, K; ATHANASIADIS, A et al.Annals of oncology. 2004, Vol 15, Num 2, pp 224-229, issn 0923-7534, 6 p.Article

Salvage treatment of metastatic breast cancer with docetaxel and carboplatin: A multicenter phase II trialMAVROUDIS, D; ALEXOPOULOS, A; GEORGOULIAS, V et al.Oncology. 2003, Vol 64, Num 3, pp 207-212, issn 0030-2414, 6 p.Article

Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF) : A phase II trialMAVROUDIS, D; KOUROUSIS, C; SARMONIS, G et al.American journal of clinical oncology. 2000, Vol 23, Num 4, pp 341-344, issn 0277-3732Article

Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor : A multicenter phase II studyANDROULAKIS, N; KOUROUSIS, C; STATHOPOULOS, G. P et al.Journal of clinical oncology. 1999, Vol 17, Num 6, pp 1779-1785, issn 0732-183XArticle

First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbineKOUROUSIS, C; ANDROULAKIS, N; KAKOLYRIS, S et al.Cancer. 1998, Vol 83, Num 10, pp 2083-2090, issn 0008-543XArticle

Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy : A multicenter phase II studyANDROULAKIS, N; KOUROUSSIS, C; KOTSAKIS, A et al.Annals of oncology. 1998, Vol 9, Num 10, pp 1127-1130, issn 0923-7534Article

A dose-escalation study of pegylated liposomal doxorubicin and oxaliplatin in patients with advanced solid tumorsKOTSAKIS, A; KOUROUSSIS, Ch; MAVROUDIS, D et al.Oncology. 2006, Vol 71, Num 3-4, pp 190-196, issn 0030-2414, 7 p.Article

A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumorsMAVROUDIS, D; PAPPAS, P; SAMONIS, G et al.Annals of oncology. 2003, Vol 14, Num 2, pp 304-312, issn 0923-7534, 9 p.Article

Irinotecan (CPT-11) in combination with infusional 5-fluorouracil and leucovorin (de Gramont regimen) as first-line treatment in patients with advanced colorectal cancer: A multicenter phase II studyVAMVAKAS, L; KAKOLYRIS, S; GEORGOULIAS, V et al.American journal of clinical oncology. 2002, Vol 25, Num 1, pp 65-70, issn 0277-3732Article

Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer : A phase II studyKOUROUSSIS, Ch; SOUGLAKOS, J; GEORGOULIAS, V et al.Oncology. 2001, Vol 61, Num 1, pp 36-41, issn 0030-2414Article

A phase I clinical trial of topotecan given every 2 weeks in patients with refractory solid tumorsKAKOLYRIS, S; KOUROUSSIS, Ch; SOUGLAKOS, J et al.Oncology. 2001, Vol 61, Num 4, pp 265-270, issn 0030-2414Article

First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II studyPAPAKOSTAS, P; KOUROUSSIS, Ch; ANDROULAKIS, N et al.European journal of cancer (1990). 2001, Vol 37, Num 15, pp 1833-1838, issn 0959-8049Article